Pages that link to "Q24658301"
Jump to navigation
Jump to search
The following pages link to Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer (Q24658301):
Displaying 50 items.
- Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression (Q21091035) (← links)
- How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion (Q24273350) (← links)
- Persistent androgen receptor addiction in castration-resistant prostate cancer (Q26777163) (← links)
- The Regulation of Steroid Action by Sulfation and Desulfation (Q26799364) (← links)
- Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy (Q26829894) (← links)
- OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies (Q27001267) (← links)
- Targeting intratumoral androgens: statins and beyond (Q28073619) (← links)
- Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO2B1) function by protein kinase C-mediated internalization. (Q30494155) (← links)
- Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes (Q30499412) (← links)
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity (Q34603829) (← links)
- Genetic variation: effect on prostate cancer. (Q34663656) (← links)
- Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers (Q34983690) (← links)
- Castration-resistant prostate cancer: new science and therapeutic prospects (Q35076264) (← links)
- SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer (Q35112055) (← links)
- Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. (Q35150765) (← links)
- Isolation of Modulators of the Liver-Specific Organic Anion-Transporting Polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae) (Q35430039) (← links)
- Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment (Q35451892) (← links)
- The expression and function of organic anion transporting polypeptides in normal tissues and in cancer (Q35670179) (← links)
- Contribution of tumoral and host solute carriers to clinical drug response (Q38636876) (← links)
- Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients (Q36036384) (← links)
- Androgens and doping tests: genetic variation and pit-falls (Q36087942) (← links)
- A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer (Q36326889) (← links)
- Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancer (Q36524183) (← links)
- Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. (Q36616448) (← links)
- Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives (Q36711323) (← links)
- Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas (Q36800228) (← links)
- HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms (Q36877910) (← links)
- A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. (Q36953368) (← links)
- Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions (Q37120923) (← links)
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. (Q37121662) (← links)
- The genetics of castration-resistant prostate cancer: what can the germline tell us? (Q37233298) (← links)
- Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma (Q37253554) (← links)
- ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel (Q37297173) (← links)
- Bioinformatics construction of the human cell surfaceome. (Q37377413) (← links)
- Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes. (Q37583348) (← links)
- Pharmacogenetics of membrane transporters: an update on current approaches (Q37641869) (← links)
- Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors (Q37723393) (← links)
- Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy (Q37735146) (← links)
- The evolving role of familial history for prostate cancer (Q37793100) (← links)
- Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy (Q37895401) (← links)
- Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically (Q37921011) (← links)
- Current understanding of hepatic and intestinal OATP-mediated drug-drug interactions. (Q37960129) (← links)
- The androgen/androgen receptor axis in prostate cancer (Q37983462) (← links)
- Androgen action and metabolism in prostate cancer (Q37997571) (← links)
- Contribution of the OATP1B subfamily to cancer biology and treatment. (Q38046413) (← links)
- Pharmacogenetics in kidney transplantation: recent updates and potential clinical applications. (Q38063426) (← links)
- Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trial (Q38190112) (← links)
- Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression (Q38242231) (← links)
- Pharmacogenetics of membrane transporters: a review of current approaches. (Q38242601) (← links)
- Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers (Q38243217) (← links)